Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cresco Labs Q2 EPS $(0.05) Misses $(0.04) Estimate, Sales $163.624M Beat $162.714M Estimate

Author: Benzinga Newsdesk | August 07, 2025 07:51am
Cresco Labs (OTC:CRLBF) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 35.14 percent. This is a 68.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $163.624 million which beat the analyst consensus estimate of $162.714 million by 0.56 percent. This is a 11.25 percent decrease over sales of $184.356 million the same period last year.

Posted In: CRLBF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist